Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
- pharma
Pacific oyster
Concern score
Not assessed — no hazard data yet.
Why it's flagged
FDA NDC lists this ingredient in 6 active drug products and 6 total products.
Regulation
No restrictions found. Pacific oyster appears in these published regulatory listings.
- currently_marketed_ndc
- definition_level:complete
- definition_type:primary
- ingredient_type:ingredient substance
- marketed_drug_ingredient
- nsde_reference_present
- substance_class:structurally diverse
- substance_type:structurally diverse
USFDAmarketed drug occurrenceFDA NDC lists this ingredient in 6 active drug products and 6 total products.
- FDA NDC lists this ingredient in 6 active drug products and 6 total products.Source →
USFDAlisted in openFDA substanceopenFDA substance registry classifies this ingredient as structurallydiverse.
- openFDA substance registry classifies this ingredient as structurallydiverse.Source →
Evidence
No graded sources yet for Pacific oyster. We publish evidence only once a source is linked and reviewed — this ingredient is in the catalog, but has not been assessed.
Allergen profile
Canonical allergen markers detected on this ingredient. Each row is derived from the ingredient’s name or synonyms matching a known allergen class — useful when scanning a label for a specific allergy context.
- MolluscsContains · Oral (ingested)
Source: chemindex_name_match
Suitability
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Good fit
Where it appears
Prevalence of Pacific oyster in our catalog (fda_ndc).
Products
6
